ID   NA8-MEL
AC   CVCL_S599
SY   Na8-Mel; Na-8-MEL; Na-8 MEL; NA 8-MEL; Na8Mel; Na-8; NA8; Na8
DR   EFO; EFO_0022361
DR   Wikidata; Q54907361
RX   PubMed=8642259;
RX   PubMed=10752474;
RX   PubMed=14871852;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 6
//
RX   PubMed=8642259; DOI=10.1084/jem.183.3.1173; PMCID=PMC2192325;
RA   Guilloux Y., Lucas S., Brichard V.G., Van Pel A., Viret C.,
RA   De Plaen E., Brasseur F., Lethe B., Jotereau F., Boon T.;
RT   "A peptide recognized by human cytolytic T lymphocytes on HLA-A2
RT   melanomas is encoded by an intron sequence of the
RT   N-acetylglucosaminyltransferase V gene.";
RL   J. Exp. Med. 183:1173-1183(1996).
//
RX   PubMed=10752474; DOI=10.1007/s002620050015; PMCID=PMC11037162;
RA   Slingluff C.L. Jr., Colella T.A., Thompson L., Graham D.D.,
RA   Skipper J.C.A., Caldwell J., Brinckerhoff L., Kittlesen D.J.,
RA   Deacon D.H., Oei C., Harthun N.L., Huczko E.L., Hunt D.F.,
RA   Darrow T.L., Engelhard V.H.;
RT   "Melanomas with concordant loss of multiple melanocytic
RT   differentiation proteins: immune escape that may be overcome by
RT   targeting unique or undefined antigens.";
RL   Cancer Immunol. Immunother. 48:661-672(2000).
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan K.T., Coppola M.A., Gatlin C.L., Thompson L.W., Shabanowitz J.,
RA   Hunt D.F., Engelhard V.H., Ross M.M., Slingluff C.L. Jr.;
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//